ZEB1 and breast carcinoma: Yao and Yao [123] found that ABCB5 may enhance the metastasis and epithelial–mesenchymal transition (EMT) in breast cancer through the downstream effector Zinc finger E-box-binding homeobox 1 (ZEB1) (Figure 5C).